Source | Terms and limits | Hits |
WHO International Clinical Trials Registry Platform | Condition: Asthma exacerbation, date of registration from 1 March 2016 to present (any recruitment status, sponsor, location ). Condition: Asthma, Intervention: inhaled corticosteroids, date of registration from 1 March 2016 to present (any recruitment status, sponsor, location ). |
40 18 |
AstraZeneca clinical trials | Terms: Asthma exacerbation, Phases 3 or 4, Therapeutic area: respiratory (any recruitment status, sponsor, location or product). | 14 |
GlaxoSmithKline study register | Terms: asthma exacerbation, medical condition: asthma, Phases 3 or 4, study type: interventional (any recruitment status, phase, age, sex) | 99 |
OpenGrey | Terms: asthma exacerbation | 20 |
New York Academy of Medicine Grey Literature Report | Terms: asthma exacerbation | 4 |